Trial · NCT02067663
Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
NCT02067663, Completed, University of Colorado, Denver; results first posted 2019-07-05
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study. Trials, record NCT02067663. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02067663
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
- NCT number
- NCT02067663
- Status
- Completed
- Enrollment
- 123 participants, actual
- Lead sponsor
- University of Colorado, Denver
- Conditions
- Contraception
- Interventions
- Paragard, Mirena
- First posted
- 2014-02-20
- Last updated
- 2019-07-05
- Results first posted
- 2019-07-05
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | IUD Expulsion Rate | 3 months postpartum | The primary outcome of the study is the total number of expulsions in the full 3 month study period. The provider will perform a speculum exam and transvaginal ultrasound. If expulsion has occurred, the participant will have an abdominal x-ray to confirm. |
| Secondary | Pregnancy | 6 weeks | A urine pregnancy test will be performed at the 6 week follow up visit if clinically indicated. |
| Secondary | Pregnancy | 3 months | A urine pregnancy test will be performed at the 3 month follow up visit if clinically indicated. |
| Secondary | Complications | 3 months | A questionnaire will be administered to determine if the participant has had any complications since placement. Number of women reporting complications are reported. |
| Secondary | Satisfaction | 3 months | A questionnaire will be administered to determine the participant's satisfaction level with the IUD. Satisfaction levels of \>= 8 are reported by percent of participants. |
| Secondary | Intrauterine Device Expulsion (Day 1) | Day 1 | Number of expulsions at Day 1. Position of the IUD within the uterus will be documented by ultrasound. |
| Secondary | Intrauterine Device Expulsion (6 Weeks) | 6 weeks | Number of expulsions. Position of the IUD within the uterus will be documented by ultrasound. |
| Secondary | Intrauterine Device Expulsion by 12 Weeks Postpartum | 12 weeks | Position of the IUD within the uterus will be documented by ultrasound. |
Source ClinicalTrials.gov
Outcomes8
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | IUD Expulsion Rate | 3 months postpartum | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Pregnancy | 6 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Pregnancy | 3 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Complications | 3 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Satisfaction | 3 months | percent of participants | NUMBER | |
| SECONDARY | Intrauterine Device Expulsion (Day 1) | Day 1 | participants | NUMBER | |
| SECONDARY | Intrauterine Device Expulsion (6 Weeks) | 6 weeks | participants | NUMBER | |
| SECONDARY | Intrauterine Device Expulsion by 12 Weeks Postpartum | 12 weeks | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| IUD Expulsion Rate | Mirena Group | 20 | Participants | ||
| IUD Expulsion Rate | Paragard Group | 7 | Participants | ||
| Pregnancy | Mirena Group | 0 | Participants | ||
| Pregnancy | Paragard Group | 0 | Participants | ||
| Pregnancy | Mirena Group | 0 | Participants | ||
| Pregnancy | Paragard Group | 0 | Participants | ||
| Complications | Mirena Group | 0 | Participants | ||
| Complications | Paragard Group | 0 | Participants | ||
| Satisfaction | Mirena Group | 91.4 | percent of participants | ||
| Satisfaction | Paragard Group | 94.2 | percent of participants |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Mirena Group | 68 | |
| Overall Study | STARTED | Paragard Group | 55 | |
| Overall Study | COMPLETED | Mirena Group | 55 | |
| Overall Study | COMPLETED | Paragard Group | 41 | |
| Overall Study | NOT COMPLETED | Mirena Group | 13 | |
| Overall Study | NOT COMPLETED | Paragard Group | 14 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Mirena Group | ||
| Total, all-cause mortality | Paragard Group | ||
| Total, other adverse events | Mirena Group | 0 | 68 |
| Total, other adverse events | Paragard Group | 0 | 55 |
| Total, serious adverse events | Mirena Group | 0 | 68 |
| Total, serious adverse events | Paragard Group | 0 | 55 |
Source ClinicalTrials.gov
Papers32
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons8
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Mirena Group vs Paragard Group: Pregnancy | Trial comparisons |
| Mirena Group vs Paragard Group: IUD Expulsion Rate | Trial comparisons |
| Mirena Group vs Paragard Group: Pregnancy | Trial comparisons |
| Mirena Group vs Paragard Group: Intrauterine Device Expulsion (6 Weeks) | Trial comparisons |
| Mirena Group vs Paragard Group: Intrauterine Device Expulsion (Day 1) | Trial comparisons |
| Mirena Group vs Paragard Group: Complications | Trial comparisons |
| Mirena Group vs Paragard Group: Intrauterine Device Expulsion by 12 Weeks Postpartum | Trial comparisons |
| Mirena Group vs Paragard Group: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02067663
GET https://conductscience.org/api/trials/v1/NCT02067663/papers?page=2